CALTERIDOL

Details

Stereochemistry	RACEMIC
Molecular Formula	C17H29N4O7.Ca.H
Molecular Weight	442.521
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H+].[Ca++].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1

InChI

InChIKey=RAQFSPBEADBVMP-UHFFFAOYSA-L

InChI=1S/C17H32N4O7.Ca/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+2/p-2

HIDE SMILES / InChI

Description
Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19981217&CC=WO&NR=9856776A1&KC=A1 | http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&s1=%2720100226943%27.PGNR.&OS=DN/20100226943&RS=DN/20100226943

Calteridol is tetraazacyclododecane-1,4,7-triacetic acid derivative patented by Bracco and Dibra S.P.A.

Originator

Approval Year

Patents

Name

Type

Language

(±)-CALTERIDOL

Preferred Name

English

CALTERIDOL

Official Name

English

CALCIATE(1-), (10-(2-(HYDROXY-.KAPPA.O)PROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-)-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7,.KAPPA.N10,.KAPPA.O1,.KAPPA.O4,.KAPPA.O7)-, HYDROGEN

Common Name

English

calteridol [INN]

Common Name

English

1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2-HYDROXYPROPYL)-, CALCIUM COMPLEX

Common Name

English

CALTERIDOL, (±)-

Common Name

English

Code System Code Type Description

CAS

132722-73-7